Search

Roche Holding AG

Затворен

294.8 -1.01

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

294.6

Максимум

299.2

Настроения в новините

By Acuity

25%

75%

Roche Holding AG Графика

Свързани новини

7.08.2024 г., 07:03 ч. UTC

Придобивния, сливания и поглъщания

Roche Weighs Divestment of Cancer Data Startup, FT Reports

5.08.2024 г., 22:43 ч. UTC

Печалби

Poseida Rises After Reporting Smaller-Than-Seen Loss, Partnership Progress

25.07.2024 г., 07:14 ч. UTC

Печалби

Roche Raises Earnings Guidance After Results Beat Market Expectations -- Update

25.07.2024 г., 05:49 ч. UTC

Печалби

Roche Raises Guidance After Sales, Earnings Beat Market Expectations

20.06.2024 г., 23:05 ч. UTC

Значими двигатели на пазара

Sarepta Shares Soar 37% Following Expanded Approval for Elevidys

19.08.2024 г., 20:01 ч. UTC

Печалби

IBD 50 Stock TG Therapeutics Breaks Out Bullishly After 'Solid' Quarter -- IBD

7.08.2024 г., 14:22 ч. UTC

Топ новини
Печалби

It Isn't Time to Worry About Wegovy Yet -- Heard on the Street -- WSJ

29.07.2024 г., 05:04 ч. UTC

Придобивния, сливания и поглъщания

Roche: Deal Was Announced at the End of 2023

29.07.2024 г., 05:03 ч. UTC

Придобивния, сливания и поглъщания

Roche: To Move on the Full Integration of the Acquisition

29.07.2024 г., 05:02 ч. UTC

Придобивния, сливания и поглъщания

Roche: Acquisition Received All Required Antitrust and Regulatory Clearances

29.07.2024 г., 05:01 ч. UTC

Придобивния, сливания и поглъщания

Roche Closes Acquisition of LumiraDx's Point of Care Technology

25.07.2024 г., 13:20 ч. UTC

Печалби

AstraZeneca Slides Despite Beating Quarterly Expectations And Hiking Its Outlook -- IBD

25.07.2024 г., 07:35 ч. UTC

Пазарно говорене
Печалби

Roche Surprises With Guidance Lift -- Market Talk

25.07.2024 г., 05:10 ч. UTC

Печалби

Roche 1H Oper Pft CHF9.07B

25.07.2024 г., 05:10 ч. UTC

Печалби

Roche 1H Net Pft CHF6.26B

25.07.2024 г., 05:08 ч. UTC

Печалби

Roche Had Seen Core Earnings Per Share Grow Mid-Single-Digit At Constant Currency When Excluding Impact From Tax Disputes in 2023

25.07.2024 г., 05:06 ч. UTC

Печалби

Roche Expects To Further Increase Its Dividend in 2024

25.07.2024 г., 05:06 ч. UTC

Печалби

Roche Sees 2024 Core Earnings Per Share To Grow High Single Digit At Constant Currency When Excluding Impact From Tax Disputes in 2023

25.07.2024 г., 05:04 ч. UTC

Печалби

Roche Expects an Increase in Group Sales in the Mid Single Digit Range at Constant Currency

25.07.2024 г., 05:03 ч. UTC

Печалби

Roche Raises 2024 View

25.07.2024 г., 05:03 ч. UTC

Печалби

Roche 1H Diagnostics Sales Rose 5% at Constant Currency

25.07.2024 г., 05:02 ч. UTC

Печалби

Roche 1H Pharmaceutical Sales Rose 5% at Constant Currency

25.07.2024 г., 05:02 ч. UTC

Печалби

Roche 1H Sales Grew 5% at Constant Currency

25.07.2024 г., 05:02 ч. UTC

Печалби

Analysts Saw Roche 1H Core EPS at CHF9.24

25.07.2024 г., 05:02 ч. UTC

Печалби

Roche 1H Adj EPS CHF10.23

25.07.2024 г., 05:01 ч. UTC

Печалби

Analysts Saw Roche 1H Sales at CHF29.38B

25.07.2024 г., 05:01 ч. UTC

Печалби

Roche 1H Sales CHF29.85B

5.07.2024 г., 08:16 ч. UTC

Пазарно говорене

Roche's FDA Approval for Eye Drug Won't Be a Game Changer -- Market Talk

4.07.2024 г., 08:29 ч. UTC

Пазарно говорене

Roche's Halted Lung Cancer Trial Doesn't Come as a Surprise -- Market Talk

17.06.2024 г., 09:13 ч. UTC

Пазарно говорене

Roche Defends Blood Disorder Drug as Competition from Novo Nordisk Looms -- Market Talk

Roche Holding AG Прогноза

Настроение

By Acuity

Настроения в новините

Много силни бичи доказателства

Волатилност

Под средното

Обем новини (RCV)

Под средното